Literature DB >> 636865

Transtympanic electrocochleography during glycerol dehydration.

D A Moffat, W P Gibson, R T Ramsden, A W Morrison, J B Booth.   

Abstract

Thirteen patients with Meniere's disorder were tested using transtympanic electrocochleography during glycerol dehydration. The most common finding was a decrease in the negative summating potential and this appeared to be a more sensitive indicator of changes occurring in the cochlea than pure tone audiometry and speech discrimination. A pathophysiological explanation for this observation is offered and the possibility of using this decrease in the negative summating potential as a pointer to the prognosis of endolymphatic sac surgery is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 636865     DOI: 10.3109/00016487809111922

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

1.  Meniere's Syndrome.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Meniere's disease: the selection and assessment of patients for surgery using electrocochleography.

Authors:  J B Booth
Journal:  Ann R Coll Surg Engl       Date:  1980-11       Impact factor: 1.891

3.  The effect of glycerol on cochlear function and ionic concentration.

Authors:  J Cohen; T Morizono; C Long
Journal:  Arch Otorhinolaryngol       Date:  1985

4.  Glycerol-induced changes in the cochlear responses of the guinea pig hydropic ear.

Authors:  K C Horner; Y Cazals
Journal:  Arch Otorhinolaryngol       Date:  1987

5.  Summating potentials in Menière's disease.

Authors:  J J Eggermont
Journal:  Arch Otorhinolaryngol       Date:  1979

Review 6.  Ups and Downs in 75 Years of Electrocochleography.

Authors:  Jos J Eggermont
Journal:  Front Syst Neurosci       Date:  2017-01-24

Review 7.  Tone Burst Electrocochleography for the Diagnosis of Clinically Certain Meniere's Disease.

Authors:  Jeremy Hornibrook
Journal:  Front Neurosci       Date:  2017-06-16       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.